EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From Multi‐Omics to Visualization and Beyond: Bridging Micro and Macro Insights in CAR‐T Cell Therapy

Yuting Gong, Peng Fei, Yicheng Zhang, Yang Xu iD, Jia Wei iD

Advanced Science · 2025-05 · 12 (20)

DOI: 10.1002/advs.202501095 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 11.05.2025. Verfasst von Yuting Gong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Genomics, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 222 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Key Technologies Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor T (CAR‐T) cell therapies, a cornerstone of immunotherapy, have demonstrated remarkable efficacy in treating hematological malignancies and have more recently expanded into applications for solid tumors and autoimmune diseases. Emerging multidimensional profiling technologies offer promising solutions for enhancing CAR‐T efficacy, overcoming resistance, and facilitating the development of novel CAR‐T constructs. The integration of genomics, epigenomics, transcriptomics, proteomics, metabolomics, and microbiomics enables a comprehensive understanding of the intrinsic mechanisms underlying CAR‐T therapy, while single‐cell and spatial omics significantly improve data resolution and analytical depth. Coupled with advances in biomedical engineering, visualization technologies form the foundation for omics data generation by bridging microscopic and macroscopic scales and enabling dynamic, 3D in vivo monitoring of CAR‐T behavior. Artificial intelligence (AI) further supports this framework by enabling the analysis of complex, high‐dimensional datasets. This review highlights recent advances in the integration of multidimensional omics within CAR‐T therapy and explores cutting‐edge developments in visualization technologies and AI applications. The full convergence of multi‐omics, visualization tools, and AI is poised to deliver transformative insights into the mechanisms governing CAR‐T cell therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunotherapy, AdoptiveGenomicsReceptors, Chimeric AntigenHumansProteomicsMetabolomicsArtificial IntelligenceMultiomics

Stichwörter der Autor:innen

CAR‐T therapyartificial intelligencemulti‐omicssingle cell sequencingspatial omicstumor microenvironmentvisualization

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China.
  • Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei, 430030, China.
  • School of Optical and Electronic Information-Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and Technology, Wuhan, Hubei, 430074, China.
  • Advanced Biomedical Imaging Facility, Huazhong University of Science and Technology, Wuhan, Hubei, 430074, China.
  • Key Laboratory of Organ Transplantation, Ministry of Education, NHC Key Laboratory of Organ Transplantation, Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, Hubei, 430030, China.
  • National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, China.

ORCID-Profile: Yang Xu, Jia Wei

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Key Technologies Research and Development Program
  • National High-tech Research and Development Program

Zitieren

APA

Gong, Y., Fei, P., Zhang, Y., Xu, Y., & Wei, J. (2025). From Multi‐Omics to Visualization and Beyond: Bridging Micro and Macro Insights in CAR‐T Cell Therapy. Advanced Science, 12(20). https://doi.org/10.1002/advs.202501095

Vancouver

Gong Y, Fei P, Zhang Y, Xu Y, Wei J. From Multi‐Omics to Visualization and Beyond: Bridging Micro and Macro Insights in CAR‐T Cell Therapy. Advanced Science. 2025;12(20). doi:10.1002/advs.202501095

BibTeX
@article{Gong2025,
  author = {Gong, Yuting and Fei, Peng and Zhang, Yicheng and Xu, Yang and Wei, Jia},
  title = {From Multi‐Omics to Visualization and Beyond: Bridging Micro and Macro Insights in CAR‐T Cell Therapy},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {20},
  doi = {10.1002/advs.202501095}
}
Kostenlos starten →